Cargando…

Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection

OBJECTIVES: We investigated JNJ-64530440 (a hepatitis B virus capsid assembly modulator) safety, antiviral activity and pharmacokinetics in patients with chronic hepatitis B (CHB) (Phase 1b, NCT03439488). METHODS: Twenty treatment-naive, HBeAg-positive or -negative CHB patients were randomized 4‍:‍1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gane, Ed J., Schwabe, Christian, Berliba, Elina, Tangkijvanich, Pisit, Jucov, Alina, Ghicavii, Nelea, Verbinnen, Thierry, Lenz, Oliver, Talloen, Willem, Kakuda, Thomas N., Westland, Chris, Patel, Megha, Yogaratnam, Jeysen Z., Dragone, Leonard, Van Remoortere, Pieter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969529/ https://www.ncbi.nlm.nih.gov/pubmed/35040959 http://dx.doi.org/10.1093/jac/dkab491

Ejemplares similares

Drug‐Drug Interactions With the Hepatitis B Virus Capsid Assembly Modulator JNJ‐56136379 (Bersacapavir)
por: Vandenbossche, Joris, et al.
Publicado: (2022)

Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection
por: Janssen, Harry L A, et al.
Publicado: (2023)

Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB‐506 from Phase 1 studies in healthy subjects and those with hepatitis B
por: Yuen, Man‐Fung, et al.
Publicado: (2022)

Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection
por: Bourgeois, Stefan, et al.
Publicado: (2017)

Virology analysis in HCV genotype 1-infected patients treated with the combination of simeprevir and TMC647055/ritonavir, with and without ribavirin, and JNJ-56914845
por: Vijgen, Leen, et al.
Publicado: (2017)

Binding characteristics of pyrrole-scaffold hepatitis B virus capsid inhibitors and identification of novel potent compounds
por: Ruengsatra, Tanachote, et al.
Publicado: (2023)

Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534
por: Xue, Xiaohua, et al.
Publicado: (2021)

Use of Hepatitis B-e Antigen to Identify Pregnant Women With Hepatitis B Virus Infection Who Need Antiviral Therapy for Prevention of Mother-to-child Transmission
por: Jiragraivutidej, Chanya, et al.
Publicado: (2021)

Human-Centered Design of Mobile Health Apps for Older Adults: Systematic Review and Narrative Synthesis
por: Nimmanterdwong, Zethapong, et al.
Publicado: (2022)

A randomized phase 1b trial of the active site polymerase inhibitor nucleotide ATI‐2173 in patients with chronic hepatitis B virus infection
por: Squires, Katherine E., et al.
Publicado: (2022)

JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted Listeria monocytogenes–Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies
por: Brahmer, Julie R., et al.
Publicado: (2020)

Hepatitis B Virus HBx Activates Notch Signaling via Delta-Like 4/Notch1 in Hepatocellular Carcinoma
por: Kongkavitoon, Pornrat, et al.
Publicado: (2016)

Regulatory Functions and Mechanisms of Circular RNAs in Hepatic Stellate Cell Activation and Liver Fibrosis
por: Nokkeaw, Archittapon, et al.
Publicado: (2023)

An innovative wireless electrochemical card sensor for field-deployable diagnostics of Hepatitis B surface antigen
por: Teengam, Prinjaporn, et al.
Publicado: (2023)

JNJ-26481585 primes rhabdomyosarcoma cells for chemotherapeutics by engaging the mitochondrial pathway of apoptosis
por: Heinicke, Ulrike, et al.
Publicado: (2015)

Author Correction: Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534
por: Xue, Xiaohua, et al.
Publicado: (2022)

Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET
por: Neijssen, Joost, et al.
Publicado: (2021)

A study on the effect of JNJ-10397049 on proliferation and differentiation of neural precursor cells
por: Karami, Neda, et al.
Publicado: (2022)

Safety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects
por: McClure, Matthew W., et al.
Publicado: (2018)

Autophagy Related-Protein 16-1 Up-Regulated in Hepatitis B Virus-Related Hepatocellular Carcinoma and Impaired Apoptosis
por: Peantum, Jiaranai, et al.
Publicado: (2018)

Changes in transient elastography in early cirrhotic patients after receiving nonselective B‐blocker for primary variceal bleeding prophylaxis: Three‐month follow up
por: Piyachaturawat, Panida, et al.
Publicado: (2018)

The Association of PNPLA3, COX-2 and DHCR7 Polymorphisms with Advanced Liver Fibrosis in Patients with HCV Mono-Infection and HCV/HIV Co-Infection
por: Kiatbumrung, Rattanaporn, et al.
Publicado: (2018)

Association of NTCP polymorphisms with clinical outcome of hepatitis B infection in Thai individuals
por: Chuaypen, Natthaya, et al.
Publicado: (2019)

Acute liver failure and death predictors in patients with dengue-induced severe hepatitis
por: Teerasarntipan, Tongluk, et al.
Publicado: (2020)

Transcriptomic Analyses Reveal Long Non-Coding RNA in Peripheral Blood Mononuclear Cells as a Novel Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Kunadirek, Pattapon, et al.
Publicado: (2022)

Long non-coding RNA H19 promotes proliferation in hepatocellular carcinoma cells via H19/miR-107/CDK6 axis
por: NOKKEAW, ARCHITTAPON, et al.
Publicado: (2023)

Predictive Role of Pretreatment Circulating miR-221 in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Pinjaroen, Nutcha, et al.
Publicado: (2023)

Circulating Extracellular Vesicle-Derived microRNAs as Novel Diagnostic and Prognostic Biomarkers for Non-Viral-Related Hepatocellular Carcinoma
por: Boonkaew, Bootsakorn, et al.
Publicado: (2023)

Crystal Structure of Aura Virus Capsid Protease and Its Complex with Dioxane: New Insights into Capsid-Glycoprotein Molecular Contacts
por: Aggarwal, Megha, et al.
Publicado: (2012)

Prevalence of Thymine—Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection
por: Thong, Vo Duy, et al.
Publicado: (2015)

Preclinical evaluation of the antipsychotic potential of the mGlu2-positive allosteric modulator JNJ-40411813
por: Lavreysen, Hilde, et al.
Publicado: (2015)

1958. Antiviral Effects, Pharmacokinetics (PK), and Safety of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678 (JNJ-8678), in RSV-infected Infants With Bronchiolitis, in the Phase 1b Study 53718678RSV1005
por: Martinon-Torres, Federico, et al.
Publicado: (2018)

Risk factors of chronic hepatitis in antiretroviral-treated HIV infection, without hepatitis B or C viral infection
por: Chalermchai, Thep, et al.
Publicado: (2013)

Increased ATG5-ATG12 in hepatitis B virus-associated hepatocellular carcinoma and their role in apoptosis
por: Kunanopparat, Areerat, et al.
Publicado: (2016)

Neck circumference as a screening measure for identifying NAFLD among a group of academic employees in Bangkok, Thailand
por: Suwimol, Sapwarobol, et al.
Publicado: (2022)

Clinical Utility of SCALE-B to Predict Hepatitis B Virus Relapse, Hepatitis B Surface Antigen Loss After Antiviral Cessation in Asian Patients After 2-Year Follow-up
por: Kaewdech, Apichat, et al.
Publicado: (2022)

Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: Role of metabolic derangement and host genetic variants
por: Chuaypen, Natthaya, et al.
Publicado: (2022)

The LIN28B/TGF-β/TGFBI feedback loop promotes cell migration and tumour initiation potential in cholangiocarcinoma
por: Puthdee, Nattapong, et al.
Publicado: (2021)

Litchi-Derived Polyphenol Alleviates Liver Steatosis and Gut Dysbiosis in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Double-Blinded, Placebo-Controlled Study
por: Jinato, Thananya, et al.
Publicado: (2022)

Assessment and validation of the TREAT-B score to assess the treatment eligibility of patients with chronic hepatitis B virus infection
por: Thanapirom, Kessarin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kjrf4jlds39ohdi66u3frm66cg